OpenAI researcher Miles Wang in talks to launch AI drug discovery startup at $2B valuation
Lightspeed is in discussions to lead the funding round for the venture, which would focus on AI-driven drug discovery. Wang is a researcher at OpenAI known for contributions to language models.
Featured · Miles Wang
1 source
Daily brief
Get tomorrow's AI brief in your inbox
More stories today
- LeVJEPA video pretraining matches V-JEPA 2 at 20x less compute
- Anthropic joins AI rivalry, Reddit users react
- Reverse-Skill routes AI agents to cybersecurity methods
- Google AI Overviews may be hurting Wikipedia, study suggests
- Fal criticized for attacking FastH3 open release